Stockholm Stock Exchange | Large Cap
Sobi
+43.00%
Latest
+24.74%
3 months
Jefferies InternationalMorgan StanleyDeutsche BankSEBMorningstarJefferiesDanske BankCarnegiePareto SecuritiesDNBNordea MarketsKepler CheuvreuxBarclaysDNB MarketsHandelsbanken Capital MarketsHandelsbankenDanske Bank MarketsSEB EquitiesABG Sundal Collier

About The Company

Swedish Orphan Biovitrum (Sobi) is a pharmaceutical company with two focus areas: haemophilia and rare diseases. Sobi is a merger of Swedish Orphan and Biovitrum. The company has its premises in Karolinska Institutet Science Park in Solna.
Wikipedia